(Q35178553)

English

Cardiovascular effects of atomoxetine in children, adolescents, and adults

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

Cardiovascular effects of atomoxetine in children, adolescents, and adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Joachim F Wernicke

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Douglas Faries

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Donald Girod

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Jeffrey Brown

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Haitao Gao

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Douglas Kelsey

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Humberto Quintana

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Robert Lipetz

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

David Michelson

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

John Heiligenstein

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

729-740

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Correlates of ADHD in Females: Findings From a Large Group of Girls Ascertained From Pediatric and Psychiatric Referral Sources

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenylpropanolamine and other over-the-counter vasoactive compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rate-corrected QT interval: techniques and limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12862507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002018-200326100-00006

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35178553&oldid=2197320726"